 
    DexCom, Inc. is a leading player in the healthcare sector, specializing in continuous glucose monitoring systems. With a consistent focus on innovation, DexCom provides advanced solutions for diabetes management, enhancing the quality of life for millions globally. The company's strategic collaborations and cutting-edge products suggest a promising future.
The fundamental analysis of DexCom indicates strengths in several financial ratios, though some areas such as debt need improvement.
| Category | Score | Visual | 
|---|---|---|
| Overall Score | 3 | |
| Discounted Cash Flow | 3 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 1 | 
The historical data provides insight into DexCom's financial performance over time, showing consistency in certain metrics.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B | 
|---|---|---|---|---|---|---|---|
| 2025-08-29 | 3 | 3 | 5 | 5 | 1 | 1 | 1 | 
| Previous | 0 | 3 | 5 | 5 | 1 | 1 | 1 | 
Analysts project a wide range for DexCom's stock price, indicating strong potential upside with some risks involved.
| High | Low | Median | Consensus | 
|---|---|---|---|
| 146 | 28.125 | 95 | 81.36 | 
 
Analysts are predominantly positive on DexCom, with a majority recommending "Buy", supported by strong growth prospects.
| Recommendation | Count | Visual | 
|---|---|---|
| Strong Buy | 1 | |
| Buy | 36 | |
| Hold | 11 | |
| Sell | 1 | |
| Strong Sell | 0 | 
DexCom, Inc. showcases a robust business model with innovative products in the healthcare sector. While the debt levels warrant attention, the company's strong performance in other financial metrics reflects its potential for growth. Analyst targets demonstrate a general optimism, although the range of predictions indicates some volatility. Overall, DexCom remains an attractive investment prospect for those interested in the medical device field. Investors should consider the dynamic nature of the healthcare industry and market variations before investing.